Cardiac troponins are cardio-specific and are widely used for the early diagnosis and triage of patients with acute coronary syndromes in conjunction with clinical history, electrocardiographic changes and imaging. Troponin is also useful for the prediction of outcomes in acute coronary syndromes, renal failure, sepsis, and critically ill patients. New developments in assay technology, designated as high sensitivity troponins, permit detection of lower levels of troponin in most healthy individuals, earlier diagnosis of myocardial infarction, and prognosis of stable coronary disease in the community.
AwTC. Troponin — Keep up or be left behind. Malaysian J Med Sci. 2010;17(4):1–3.
2.
SaengerAKJaffeAS. The use of biomarkers for the evaluation and treatment of patients with acute coronary syndromes. Med Clin North Am2007;91(4):657–81.
3.
AntmanEMBassandJPKleinWOhmanMSendonJLPRydenL. Myocardial infarction redefined. A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol2000;36:959–69.
4.
ThygesenKAlpertJS, White HD on behalf of the Joint European Society of Cardiology/American College of Cardiology/American Heart Association/World Heart Federation task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. Eur Heart J2007;28:2525–2538.
5.
ThygesenKMairJKatusHPlebaniMVengePCollinsonP. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Consensus document of the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J2010;31:2197–2206.
6.
ChristensonRHPhillipsD. Sensitive and high sensitivity next generation cardiac troponin assays: More than just a name. Pathology2011;43(3):213–9.
7.
AppleFSCollinsonPO. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem2012;58(1):54–61.
8.
AppleFSSimpsonPAMurakamiMM. Defining the serum 99th percentile in a normal reference population measured by a high-sensitivity cardiac troponin I assay. Clin Biochem2010;43:1034–6.
9.
GiannitsisEKurzKHallemayerKJaruschJJaffeASKatusHA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem2010; 56:254–261.
10.
KoerbinGTateJRHickmanPE. Analytical characteristics of the Roche highly sensitive troponin T assay and its application to a cardio-healthy population. Ann Clin Biochem2010;47:524–8.
11.
AwTCPuaSKYewLLimWRTanSP. Performance of a new rapid automated high sensitive Troponin T (hs-TnT) immunoassay. Clin Chem2010;56(6)Suppl:A133–134(Abstract C-88).
WrightRSAndersonJLAdamsCDBridgesCRCaseyDEJrEttingerSM. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol2011;57(19):e215–367.
14.
O'ConnorREBradyWBrooksSCDiercksDEganJGhaemmaghamiC. Part 10: Acute coronary syndromes: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation2010;122(18Suppl 3):S787–817.
15.
HammCWBassandJPAgewallSBaxJBoersmaEBuenoH. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J2011;32(23):2999–3054.
16.
MelansonSEMorrowDAJarolimP. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am J Clin Pathol2007;128:282–6.
17.
KellerTZellerTPeetzDTzikasSRothACzyzE. Sensitive troponin I assay in the early diagnosis of acute myocardial infarction. N Engl J Med2009;361:868–77.
18.
ReichlinTHochholzerWBassettiSSteuerSStelzigCHartwigerS. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med2009;361:858–67.
19.
Chenevier-GobeauxCMeuneCBlancM-CCynoberLJaffrayPLefevreG. Analytical evaluation of a high-sensitivity troponin T assay and its clinical assessment in acute coronary syndrome. Ann Clin Biochem2011; 48:452–8.
20.
KellerTZellerTOjedaFTzikasSLillpoppLSinningC. Serial changes in highly sensitive Troponin I assay and early diagnosis of myocardial infarction. JAMA2011;306:2684–93.
21.
ReiterMTwerenboldRReichlinTHaafPPeterFMeissnerJ. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J2011; 32:1379–89.
22.
BodyRCarleySMcDowellGJaffeASFranceMCruickshankK. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J Am Coll Cardiol2011;58:1332–9.
23.
AldousSJRichardsAMCullenLThanMP. Early dynamic change in high-sensitivity cardiac troponin T in the investigation of acute myocardial infarction. Clin Chem2011;57(8):1154–60.
24.
MuellerMBienerMVafaieMDoerrSKellerTBlankenbergS. Absolute and Relative Kinetic Changes of High-Sensitivity Cardiac Troponin T in Acute Coronary Syndrome and in Patients with Increased Troponin in the Absence of Acute Coronary Syndrome. Clin Chem2012;58:209–18.
25.
BonacaMSciricaBSabatineMDalbyASpinarJMurphySA. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I. J Am Coll Cardiol2010;55:2118–24.
26.
GiannitsisEBeckerMKurzKHessGZdunekDKatusHA. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin Chem2010;56:642–50.
27.
LindahlBVengePJamesS. The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromes, Am Heart J2010;160:224–9.
28.
HochholzerWReichlinTTwerenboldRStelzigCHochholzerKMeissnerJ. Incremental value of high-sensitivity cardiac troponin T for risk prediction in patients with suspected acute myocardial infarction. Clin Chem2011;57(9):1318–26.
29.
MillsNLChurchhouseAMDLeeKKAnandAGambleDShahASV. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA2011:305:1210–6.
30.
NdrepepaGBraunSMehilliJBirkmeierKAByrneRAOttI. Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin. Am Heart J2011;161:68–75.
31.
WeberMBazzinoOEstradaJLNde MiguelRSalzbergSFuselliJJ. Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome. Am Heart J2011;162:81–8.
32.
NdrepepaGBraunSSchulzSByrneRAPacheJMehilliJ. Comparison of prognostic value of high-sensitivity and conventional troponin T in patients with non-ST-segment elevation acute coronary syndromes. Clin Chim Acta2011;412:1350–6.
KavsakPAHillSASupapolWBDevereauxPJWorsterA. Biomarkers for predicting serious cardiac outcomes at 72 hours in patients presenting early after chest pain onset with symptoms of acute coronary syndromes. Clin Chem2012;58:298–302.
35.
KelleyWEJanuzziJLChristensonRH. Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. Clin Chem. 2009;55(12): 2098–2112.
36.
AgewallSGiannitsisEJernbergTKatusH. Troponin elevation in coronary vs. non-coronary disease. Eur Heart J2011;32(4):404–11.
37.
PatilHVaidyaOBogartD. A review of causes and systemic approach to cardiac troponin elevation. Clin Cardiol2011;34(12):723–8.
McFallsEOLarsenGJohnsonGRAppleFSGoldmanSAraiA. Outcomes of hospitalized patients with non-acute coronary syndrome and elevated cardiac troponin level. Am J Med2011;124(7):630–5.
40.
de FilippiCRde LemosJAChristensonRHGottdienerJSKopWJZhanM. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA2010;304:2494–502.
41.
TsutamotoTKawaharaCNishiyamaKYamajiMFujiiMYamamotoT. Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure. Am Heart J2010;159(1):63–7.
42.
KawaharaCTsutamotoTSakaiHNishiyamaKYamajiMFujiiM. Prognostic value of serial measurements of highly sensitive cardiac troponin I in stable outpatients with non-ischemic chronic heart failure. Am Heart J2011;162(4):639–45.
43.
SchulzOReinickeMBerghoeferGHBenschRKraemerJSchimkeI. High-sensitive cardiac troponin I (hs-cTnI) values in patients with stable cardiovascular disease: An initial foray. Clin Chim Acta2010; 411:812–7.
44.
KavsakPAXuLYusufSMcQueenMJ. High-sensitivity cardiac Troponin I measurement for risk stratification in a stable high-risk population. Clin Chem2011;57(8): 1146–53.
45.
SaundersJTNambiVde LemosJAChamblessLEViraniSSBoerwinkleE. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation2011;123:1367–76.
46.
de LemosJADraznerMHOmlandTAyersCRKheraARohatgiA. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA2010;304:2503–12.
47.
XuRYePLuoLXiaoWShengLWuH. Association between high-sensitivity cardiac troponin T and predicted cardiovascular risks in a community-based population. Int J Cardiol2011;254–6.
48.
AppleFS. High-sensitivity cardiac Troponin for screening large populations of healthy people: Is there risk?Clin Chem2011;57(4):537–9.
49.
SongDde ZoysaJRNgAChiuW. Troponins in acute kidney injury. Ren Fail. 2012;34(1):35–39.
50.
SnidermanADSolhpourAAlamAWilliamsKSloandJA. Cardiovascular death in dialysis patients: Lessons we can learn from AURORA. Clin J Am Soc Nephrol2010;5(2): 335–40.
51.
RifaiNAnnesleyTMBergJPBrugnaraCDelvinELambEJ. An appeal to medical journal editors: The need for a full description of laboratory methods and specimen handling in clinical study reports. Clin Chem2012;58(1):483–5.
52.
UngererJPJMarquatLO'RourkePKWilgenUPretoriusCJ. Concordance, variance, and outliers in 4 contemporary cardiac troponin assays: Implications for harmonization. Clin Chem2012;58(1):274–83.
53.
PanteghiniMBunkDMChristensonRHKatrukhaAPorterRASchimmelH. IFCC Working Group on Standardization of Troponin I. Standardization of troponin I measurements: An update. Clin Chem Lab Med2008;46(11):1501–6.
54.
AppleFS. Standardization of Cardiac Troponin I Assays Will Not Occur in My Lifetime. Clin Chem2012;58(1): 169–71.
55.
ChristensonRHBunkDMSchimmelH, Tate JR; on behalf of the IFCC Working Group on Standardization of Troponin I. Put Simply, Standardization of Cardiac Troponin I Is Complicated. Clin Chem2012;58(1):165–8.
56.
JaffeASVasileVCMiloneMSaengerAKOlsonKNAppleFS. Diseased skeletal muscle: A non-cardiac source of increased circulating concentrations of cardiac troponin T. J Am Coll Cardiol2011;58:1819–24.
57.
DiercksDBPeacockWFIVHollanderJESingerAJBirkhahnRShapiroN. Diagnostic accuracy of a point-of-care troponin I assay for acute myocardial infarction within 3 hours after presentation in early presenters to the emergency department with chest pain. Am Heart J2012;163(1):74–80.
58.
CelikSGiannitsisEWollertKCSchwöbelKLossnitzerDHilbelT. Cardiac troponin T concentrations above the 99th percentile value as measured by a new high-sensitivity assay predict long-term prognosis in patients with acute coronary syndromes undergoing routine early invasive strategy. Clin Res Cardiol2011;100(12):1077–85.
59.
van WijkSJacobsLEurlingsLWvan KimmenadeRLemmersRBroosP. Troponin T Measurements by High-Sensitivity vs Conventional Assays for Risk Stratification in Acute Dyspnea. Clin Chem2012;58(1):284–92.
60.
LeistnerDMKlotscheJPieperLStallaGKLehnertH, Silber S, et al. for the DETECT Study Group. Circulating Troponin as Measured by a Sensitive Assay for Cardiovascular Risk Assessment in Primary Prevention. Clin Chem2012;58(1):200–8.
61.
MorrowDACannonCPJesseRLNewbyLKRavkildeJStorrowAB; National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem2007; 53(4): 552–74.
62.
WuAHFordL. Release of cardiac troponin in acute coronary syndromes: Ischemia or necrosis?Clin Chim Acta1999;284(2):161–74.
63.
MingelsAJacobsLMichielsenESwaanenburgJWodzigWvan Dieijen-VisserM. Reference population and marathon runner sera assessment by highly sensitive troponin T and commercial cardiac troponin T and I assays. Clin Chem2009; 55:101–8.
64.
CollinsonPOHeungYMGazeDBoaFSeniorRChristensonR. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem2012;58:219–25.
65.
SaengerAKBeyrauRBraunSCoorayRDolciAFreidankH. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta2011;412:748–54.
66.
PronteraCFortunatoAStortiSMercuriALongombardoGZucchelliGC. Evaluation of analytical performance of the Siemens Advia TnI Ultra immunoassay. Clin Chem2007;53:1722–3.
67.
La'uluSLRobertsWL. Performance characteristics of five cardiac troponin I assays. Clin Chim Acta2010; 411: 1095–1101.
68.
VengePJohnstoneNLindahlBJamesS. Normal plasma levels of cardiac troponin measured by the highly sensitive cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia. J Am Coll Cardiol2009;54:1165–72.
69.
HammarstenOFuMLXSigurjonsdottirRPetzoldMSaidLLandin-WilhelmsenK. Troponin T percentiles from a random population sample, emergency room patients and patients with myocardial infarction. Clin Chem2012;58:628–37.
70.
EggersKMLindLAhlstromHBjernerTEbeling-BarbierCLarssonA. Prevalence and patho-physiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. Eur Heart J2008;29:2252–8.
71.
KatusHAGiannitsisEJaffeAS. Interpreting changes in troponin — clinical judgment is essential. Clin Chem2012;58:39–43.
